Results 91 to 100 of about 327,270 (275)

Induction of IL 2 receptor expression and cytotoxicity of thymocytes by stimulation with TCF1 [PDF]

, 1985
We investigated the role of T cell cytotoxicity inducing factor 1 (TCF1) in the induction of a cytotoxic T cell response. We found that help-deficient thymocyte cultures supplied with saturating amounts of purified IL 2 did not develop CTL in a 5-day ...
Diamantstein, T., Dröge, W., Falk, Werner, Kaltmann, B., Katzer, B., Krammer, P. H., Männel, D. N.   +6 more
core  

The effect of helper virus on Abelson virus-induced transformation of lymphoid cells [PDF]

, 1978
Abelson murine leukemia virus (A-MuLV)-transformed fibroblast nonproducer cells were used to prepare A-MuLV stocks containing a number of different helper viruses.
Baltimore, David, Rosenberg, Naomi
core   +2 more sources

Unexpected Giant Right Coronary Artery Aneurysm Diagnosed by Computed Tomography Angiography in the Emergency Department

Journal of Clinical Ultrasound, Volume 54, Issue 2, Page 509-515, February 2026.
3D Volume Rendering coronary CTA reconstruction showing a giant thrombosed aneurysm of the proximal right coronary artery ABSTRACT Giant coronary artery aneurysms (GCAA) are usually defined as diameter > 8 mm or > 400% of the adjacent normal segment; they are very rare (reported prevalence ≈0.02%).
Stefano Giusto Picchi, Giulia Lassandro, Rosita Comune, Filomena Pezzullo, Stefania Tamburrini, Giulio Cocco, Nino Cocco, Domenico Tafuri, Antonio Corvino   +8 more
wiley   +1 more source

Pathology of thymoma—where are we today? [PDF]

, 2020
Irshad Soomro
openalex   +1 more source

Unveiling a BRAF Signature Proficient in Accurately Capturing Oncogenic Activity and Guiding Prognostic Prediction Across Multiple Cancers

MedComm, Volume 7, Issue 2, February 2026.
The BRAF25 meta‐signature effectively captures BRAF‐driven oncogenic activity. By enabling precise patient stratification with distinct mutation profiles, BRAF25 identifies BRAF‐active tumor subtypes and provides superior prognostic value compared with mutation status alone.
Kaidi Yang, Shihui Fu, Jingbing Liang, Lijuan Ding, Junhao You, Fang Li, Ye Yuan, Xiu‐Wu Bian   +7 more
wiley   +1 more source

Developmental and tissue-specific expression of the Q5k gene [PDF]

, 1991
Expression of the Q5k gene was examined by northern blot analysis and polymerase chain reaction (PCR) in the AKR mouse and various cell lines, each of the H-2k haplotype.
Baeuerle, Patrick A., Bevec, Dorian, Brem, Gottfried, Schwemmle, Sabine, Urban, Manuela B., Weiss, Elisabeth H.   +5 more
core   +1 more source

Impact of Prior Intravenous Immunoglobulin and Plasmapheresis on Eculizumab or Ravulizumab Treatment for Generalized Myasthenia Gravis: An Analysis of the MG SPOTLIGHT Registry

Clinical and Experimental Neuroimmunology, Volume 17, Issue 1, February 2026.
ABSTRACT Objective The complement component 5 inhibitor therapies (C5ITs) eculizumab and ravulizumab are approved for the treatment of generalized myasthenia gravis (gMG). We evaluated the real‐world effectiveness and safety of eculizumab and ravulizumab in patients with gMG with or without prior intravenous immunoglobulin (IVIg) or plasma exchange ...
Akiyuki Uzawa, Ema Rodrigues, Hiroyuki Murai   +2 more
wiley   +1 more source

Tumours of the thymus: a cohort study of prognostic factors from the European Society of Thoracic Surgeons database [PDF]

, 2017
OBJECTIVES A retrospective database was developed by the European Society of Thoracic Surgeons, collecting patients submitted to surgery for thymic tumours to analyse clinico-pathological prognostic predictors. METHODS A total of 2151 incident cases from
Altorki, Nasser, Anile, Marco, Arame, Alex, Brioude, Geoffrey, Brunelli, Alessandro, Carbognani, Paolo, Casadio, Caterina, Cerfolio, Robert, de Antonio, David Gomez, Detterbeck, Frank, Donati, Giovanni, Evangelista, Andrea, Filosso, Pier Luigi, Foroulis, Christophoros N., Gebitekin, Cengiz, Kernstine, Kemp H., Keshavjee, Shaf, Khaled, AlKattan, Lang-Lazdunski, Loic, Lequaglie, Cosimo, Liberman, Moishe, Lim, Eric, Mancuso, Maurizio, Moser, Bernhard, Nicholson, Andrew G., Nosotti, Mario, Novoa, Nuria M., Oliaro, Alberto, Refai, Majed, Rendina, Erino, Rocco, Gaetano, Ruffini, Enrico, Saita, Salvatore, Scarci, Marco, Schützner, Jan, Terzi, Alberto, Thomas, Pascal, Toker, Alper, Van Raemdonck, Dirk, Van Veer, Hans, Venuta, Federico, Voltolini, Luca, Weder, Walter, Zurek, Wojciech   +43 more
core  

Surgical therapy of thymic tumours with pleural involvement: an ESTS Thymic Working Group Project [PDF]

, 2017
OBJECTIVES Surgery for thymic epithelial tumours (TETs) with pleural involvement is infrequently performed. Thus, the value of surgical therapy for primary or recurrent TETs with pleural involvement is not sufficiently defined yet.
Bille, Andrea, Brioude, Geoffrey, de Antonio, David Gómez, de Perrot, Marc, Fabre, Dominique, Fadel, Elie, Guerrera, Francesco, Janik, Stefan, Jungraithmayr, Wolfgang, Keshavjee, Shaf, Klepetko, Walter, Lang-Lazdunski, Loic, Liberman, Moishe, Moser, Bernhard, Novoa, Nuria, Ruffini, Enrico, Scarci, Marco, Thomas, Pascal, Van Raemdonck, Dirk, Viskens, Sophie, Weder, Walter   +20 more
core   +1 more source

1‐Year Clinical Outcome Post‐Myasthenic Crisis: A Multicenter Prospective Study in China

European Journal of Neurology, Volume 33, Issue 2, February 2026.
In this prospective cohort of 282 patients with myasthenic crisis (MC) episodes, all‐cause mortality was 15.16%. Among 247 patients who have completed 1‐year follow‐up, 79.76% achieved favorable outcomes with significant improvement in the MG‐activities of daily living (MG‐ADL) score.
Xiao Huan, Ran Chen, Lei Jin, Yuan Wang, Yafang Xu, Lei Yang, Caihua Xi, Jianming Zheng, Lijun Luo, Song Yang, Jianquan Shi, Yanping Liu, Zhe Ruan, Wanlong Wu, Wei Li, Yaoxian Yue, Yarong Li, Wenji Jia, Huahua Zhong, Chong Yan, Jie Song, Jianying Xi, Song Tan, Qilong Jiang, Zhangyu Zou, Chongbo Zhao, Sushan Luo, on behalf of the Chinese Myasthenia Gravis Collaborating Group (CMGCG), Yuzhou Guan, Yuwei Da, Huan Yang, Ting Chang, Yuge Wang, Bitao Bu, Hongyu Zhou, Chunsheng Yang, Hua Zhang, Hui Deng, Ruisheng Duan   +38 more
wiley   +1 more source